Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
2 Te Pai Place , Auckland, Auckland, 0610, NZ
Douglas CDMO offers integrated drug development services, specializing in formulating and commercially supplying innovative and generic high-potency small molecule softgels and liquids. Working with clients across the globe, we pride ourselves on delivering superior quality and excellent service.
Susan Lynch-Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.
Released By Douglas CDMO
Technical considerations for selecting your next oral dosage form.
The New Zealand-based CDMO making a global impact.
Exploring the case for softgels and CDMO partnerships with Peter Surman, Chief Scientific Officer at Douglas CDMO.
Chief Science Officer, Peter Surman, shares insight on why pharmaceutical companies should consider softgels for their next oral dosage form.
The U.S. Food and Drug Administration (FDA) approved WIDAPLIK on June 6, 2025.
By: Charlie Sternberg
Bayer’s low-dose contrast agent seeks approval for contrast-enhanced MRI of the CNS and other regions for adults and pediatric patients.
By: Rachel Klemovitch
Will enhance SGD Pharma’s capabilities and expand its market presence in Europe.
The approval covers the LP.8.1-adapted vaccine, designed to address evolving SARS-CoV-2 sublineages.
Aims to establish a hub for advanced biopharmaceutical production in the MENA region.
For potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed target in neurodegeneration.
This partnership will accelerate Ottoimo Pharma’s cancer immunotherapy’s path to clinic.
Makes targeted investments and builds new partnerships in the APAC region.
New suite in Sandwich, UK adds proprietary, CE-certified flow equipment.
BAT2206 is Bio-Thera's third EC-approved product.
Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review, and automate oversight.
By: Ken McFarlane
Provides greater choice and flexibility for spectral flow cytometry in immunology research.
Accelerated EC Decision Comes After U.S. FDA Approval in June.
With over two decades of experience, Katcheves previously served at Teva, Bristol Myers Squibb, and Lonza Group.
Bretisilocin is currently in clinical development for the treatment of patients with moderate-to-severe major depressive disorder.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
